论文部分内容阅读
目的:分析探讨布地奈德联合氨茶碱治疗稳定期慢性阻塞性肺疾病的治疗效果。方法:选取2013年12月-2014年12月于我院进行治疗的90例稳定期慢性阻塞性肺疾病患者作为研究对象,采用双盲法分为对照组和研究组,每组各45例。其中对照组给予布地奈德雾化治疗,研究组在对照组的基础上联合氨茶碱进行治疗。3个月为1疗程,观察比较两组患者治疗前后肺功能改善情况。结果:两组患者经过3个月的治疗,肺功能均比治疗前有所改善(P<0.05),并且研究组患者肺功能改善情况明显优于对照组患者,具有统计学意义(P<0.05)。结论:布地奈德联合氨茶碱治疗稳定期慢性阻塞性肺疾病的治疗效果显著,值得在临床全面推广。
Objective: To investigate the therapeutic effect of budesonide combined with aminophylline in the treatment of stable chronic obstructive pulmonary disease. Methods: Ninety patients with stable chronic obstructive pulmonary disease who were treated in our hospital from December 2013 to December 2014 were selected and divided into control group and study group by double-blind method, with 45 cases in each group. The control group received budesonide atomization therapy, and the study group was treated with aminophylline on the basis of the control group. 3 months for a course of treatment, observation and comparison of two groups of patients before and after treatment to improve pulmonary function. Results: After 3 months of treatment, the lung function of both groups improved compared with that before treatment (P <0.05), and the improvement of pulmonary function in the study group was significantly better than that in the control group (P <0.05 ). Conclusion: Budesonide combined with aminophylline in the treatment of stable chronic obstructive pulmonary disease has a significant therapeutic effect and deserves to be widely promoted in clinic.